Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.65
-0.05 (-0.19%)
At close: Jan 22, 2026, 4:00 PM EST
26.65
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:30 PM EST
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.26 billion as of January 22, 2026. Its market cap has increased by 90.52% in one year.
Market Cap
3.26B
Enterprise Value
3.15B
1-Year Change
90.52%
Ranking
Category
Stock Price
$26.65
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.26B, an increase of 316.88%. That is a compound annual growth rate of 26.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.27B | -8.06% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liquidia | 3.42B |
| Centessa Pharmaceuticals | 3.35B |
| Alumis | 3.25B |
| Xenon Pharmaceuticals | 3.21B |
| Vera Therapeutics | 3.18B |
| IDEAYA Biosciences | 3.13B |
| Viridian Therapeutics | 3.12B |
| Beam Therapeutics | 3.06B |